blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3573657

EP3573657 - METHODS OF IMMUNE MODULATION AGAINST FOREIGN AND/OR AUTO ANTIGENS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  01.11.2019
Database last updated on 12.07.2024
FormerThe international publication has been made
Status updated on  04.08.2018
Most recent event   Tooltip26.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Tang, Zequn
7001 Laurelspur Loop
San Ramon, CA 94582 / US
[2019/49]
Inventor(s)01 / see applicant
...
 [2019/49]
Representative(s)Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
[2019/49]
Application number, filing date18744918.629.01.2018
[2019/49]
WO2018US15771
Priority number, dateUS201762451759P29.01.2017         Original published format: US 201762451759 P
[2019/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018140890
Date:02.08.2018
Language:EN
[2018/31]
Type: A1 Application with search report 
No.:EP3573657
Date:04.12.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 02.08.2018 takes the place of the publication of the European patent application.
[2019/49]
Search report(s)International search report - published on:US02.08.2018
(Supplementary) European search report - dispatched on:EP15.03.2021
ClassificationIPC:A61K39/39, C07K16/28, C07K14/705, C07K16/30, A61P37/04, A61K39/00, A61P35/00
[2021/02]
CPC:
A61P37/04 (EP); A61K39/001106 (EP,US); A61K39/00 (EP);
A61K39/0007 (EP,US); A61K39/0008 (US); A61K39/0011 (EP);
A61K39/001162 (EP); A61K39/08 (US); A61K39/104 (US);
A61K39/39 (EP,US); A61P35/00 (EP); A61K2039/505 (EP,US);
A61K2039/5154 (EP); A61K2039/5156 (EP); A61K2039/53 (EP,US) (-)
C-Set:
A61K39/001106, A61K2300/00 (EP);
A61K39/001162, A61K2300/00 (EP)
Former IPC [2019/49]A61K39/39, C07K16/28, C07K14/705, C07K16/30, A61P37/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/49]
TitleGerman:VERFAHREN ZUR IMMUNMODULATION GEGEN FREMD- UND/ODER AUTO-ANTIGENE[2019/49]
English:METHODS OF IMMUNE MODULATION AGAINST FOREIGN AND/OR AUTO ANTIGENS[2019/49]
French:MÉTHODES DE MODULATION IMMUNITAIRE CONTRE DES ANTIGÈNES ÉTRANGERS ET/OU DES AUTO-ANTIGÈNES[2019/49]
Entry into regional phase29.08.2019National basic fee paid 
29.08.2019Search fee paid 
29.08.2019Designation fee(s) paid 
29.08.2019Examination fee paid 
Examination procedure24.08.2018Request for preliminary examination filed
International Preliminary Examining Authority: US
29.08.2019Examination requested  [2019/49]
08.11.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
18.01.2022Amendment by applicant (claims and/or description)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
18.01.2022Request for further processing filed
18.01.2022Full payment received (date of receipt of payment)
Request granted
25.01.2022Decision despatched
Fees paidRenewal fee
31.01.2020Renewal fee patent year 03
25.01.2021Renewal fee patent year 04
25.01.2022Renewal fee patent year 05
25.01.2023Renewal fee patent year 06
25.01.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2008011344  (CHILDRENS HOSPITAL INC [US], et al) [X] 1,2,5-14 * page 1, lines 7-10 * * page 3, paragraph l * * page 4, paragraph 3 * * page 5, paragraph 1 - page 6, paragraph 2 * * page 9, lines 20-30 * * page 10, paragraph l - page 11 * * page 12, lines 20-27 * * page 23, paragraph l - page 24, paragraph 1 * * page 28, paragraph l - page 29, paragraph 1 * * example 3 *;
 [X]US2010035973  (WALKER CHRISTOPHER [US]) [X] 1-3,6,10-14 * paragraphs [0010] - [0017] - [0020] , [0023] - [0026] - [0028] , [0031] , [0034] , [0037] , [0081] ** example 3 *;
 [X]WO2015103602  (UNIV PENNSYLVANIA [US], et al) [X] 1-3,5,6,10-14 * paragraphs [0009] - [0014] - [0017] - [0019] - [0027] , [0028] , [0030] , [0058] , [0059] , [0064] , [0075] , [0076] , [0170] , [0183]; claims 1-4, *;
 [X]WO2015123496  (IMMUNE DESIGN CORP [US]) [X] 1-3,5-7,10-14 * paragraphs [0092] - [0094] - [0139] , [0167] , [0179] - [0181] - [0192] - [0194] *;
 [X]WO2016128542  (TRANSGENE SA [FR]) [X] 1-3,5-7,10-14 * page 1, paragraph 1 * * page 6, paragraph 2 * * page 8, lines 17-19 * * page 10, paragraphs 2,l * * page 14, paragraph 2 * * page 16, lines 19-20 * * page 17, paragraph l - page 18, paragraph 1 * * page 21, paragraph l * * page 26, lines 27-29 * * page 29, paragraph l - page 30, paragraph 1 * * page 30, paragraph l - page 31, paragraph 2 * * page 46, paragraph l - page 47, paragraph 1 *;
 [A]WO2016179001  (BAYLOR COLLEGE MEDICINE [US]) [A] 1-3,5-14 * paragraphs [0006] , [0007] , [0009] - [0011] - [0013] - [0015] - [0046] - [0048] - [0067] , [0068] , [0070] - [0074] *
International search[Y]US2008286804  (KAWAKAMI YUTAKA [JP], et al) [Y] 12, 63 * ; abstract; paragraph [0008] *;
 [Y]US2014242101  (ANDERSEN MADS HALD [DK]) [Y] 39-40* ; paragraphs [0215], [0247] *;
 [Y]US2014341917  (NASTRI HORACIO G [US], et al) [Y] 2-5, 9, 26-28, 34-35 * ; paragraph [0016] *;
 [XY]WO2015175340  (BAVARIAN NORDIC INC [US]) [X] 1, 8, 13, 16, 25, 29-32, 36-38, 41-45, 52-55, 62, 64 * ; paragraphs [018], [026], [031]-[032], [043], [073], [075]-[076], [083]-[084], [0104], [0117], [0142], [0149], [0176]-[0177]; figures 3-4 * [Y] 2-5, 9-12, 17-24, 26-28, 33-35, 39-40, 63;
 [Y]US2016339090  (HACOHEN NIR [US], et al) [Y] 18-24, 35 * ; paragraphs [0044], [0078]-[0079], [0096], [0098], [0105], [0598] *;
 [Y]CN106350540  (SUZHOU INST OF SYSTEMS MEDICINE) [Y] 10-1 * ; abstract; page 3, paragraphs 2, 14 *;
 [Y]  - FATH, S et al., "Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression", PLoS One, (20110303), vol. 6, no. 3, pages 1 - 14, XP055531212 [Y] 9 * ; abstract; figure 1B; DOI: 10.1371/journal.pone.0017596 *

DOI:   http://dx.doi.org/10.1371/journal.pone.0017596
 [Y]  - SLOVIN, SF, "Targeting Novel Antigens for Prostate Cancer Treatment: Focus on Prostate-Specific Membrane Antigen", Expert Opinion on Therapeutic Agents, (20050600), vol. 9, no. 3, pages 561 - 570, XP009151257 [Y] 14-15 * ; abstract; page 2, paragraph 2; DOI: 10.1517/14728222.9.3.561 *

DOI:   http://dx.doi.org/10.1517/14728222.9.3.561
 [Y]  - GJERSTORFF, MF et al., "Oncogenic Cancer/Testis Antigens: Prime Candidates for Immunotherapy", Oncotarget, (20150630), vol. 6, no. 18, pages 15772 - 1787, XP055531241 [Y] 17 * , column 2, paragraph 2; DOI: 10.18632/oncotarget.4694 *

DOI:   http://dx.doi.org/10.18632/oncotarget.4694
 [Y]  - KREBBER, C et al., "Co-selection of Cognate Antibody-Antigen Pairs by Selectively-Infective Phages", FEBS Letters, (19951218), vol. 377, no. 2, pages 227 - 231, XP055531244 [Y] 27, 34 * ; figure 1; page 228, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/0014-5793(95)01348-2
 [Y]  - RAJANI, KR et al., Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors, (20151113), vol. 7, no. 11, pages 5889 - 5901, XP055522949 [Y] 28 * ; page 5893, paragraph 4; DOI: 10.3390/v7112914 *

DOI:   http://dx.doi.org/10.3390/v7112914
 [Y]  - FANG, RH et al., "Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery", Nano Letters, (20140327), vol. 14, no. 4, pages 2181 - 2188, XP055531640 [Y] 33 * ; figure 1; page 2182, column 2, paragraph 2 - page 2183, column 1, paragraph 1; DOI: 10.1021/nl500618u *

DOI:   http://dx.doi.org/10.1021/nl500618u
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.